|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 21, 2017 ) The North America Bovine Respiratory Disease Treatment Market has been estimated at USD 9.56 million in 2016 and is projected to reach USD 22.14 million by 2021, at a CAGR of 18.3% during the forecast period from 2016 to 2021. The U.S. feedlot industry estimates a huge annual loss for bovine respiratory disease (BRD) due to loss of production, increased labour expenses, pharmaceutical costs and death deriving from BRD.
Full report at: http://www.marketdataforecast.com/market-reports/north-america-bovine-respiratory-disease-treatment-market-909/
BRD refers to any disease of the lower or upper respiratory tracts in cattle and is commonly associated with lung infections, which can cause pneumonia. Bovine Respiratory Disease is far too common, far too costly and for the most part, seems far too hard to handle. If cattle are treated more than once, they never get back to that peak performance.
The disease is caused by variety of factors such as Host factors which includes animal age, immunity, genetics and exposure to pathogens, Environmental factors involves crowding, temperature, commingling and transport, Internal or external parasite infections and Infectious agents. The weight loss that animal has due to BRD sickness will stay with them throughout the feeding period. Hence, productivity is reduced.
Market Segmentation
By Type of Treatment
• Anti-Infectious Agents
• Anti-Parasiticides
• Bronchodilators
• Oral Rehydration Fluids
• Non-Steroidal Anti-Inflammatories
• Mucolytics
The North America bovine respiratory disease treatment market has been segmented on the basis of type of treatment into anti-infectious agents, anti-parasiticides, bronchodilators, oral rehydration fluids, non-steroidal anti-inflammatories, and mucolytic. Anti-infectious can be further sub-segmented into antibiotics and sulfas. Antibiotics and anti-inflammatory drugs are now being used for combination treatment and expected to improve the success rate of the treatment. Geographically North America market is segmented into USA and Canada.
Request sample:http://www.marketdataforecast.com/market-reports/north-america-bovine-respiratory-disease-treatment-market-909/request-sample
The major companies dominating this market by their products and services are Zoetis Inc., Merck & Co. Inc., Bayer Corporation, Eli Lilly & Co., Merial S.A.S, Boehringer Ingelheim Vetmedica, Novartis Animal Health, Vibrac S.A, Ceva Sante Animale and Vétoquinol S.A.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail: abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast
Abhishek
+1-888- 702-9626
abhishek@marketdataforecast.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
